Valuation Update With 7 Day Price Move • 10h
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥11.40, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 27% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥22.46 per share. Annuncio • Jun 30
Chengdu Wintrue Holding Co., Ltd. to Report First Half, 2026 Results on Aug 26, 2026 Chengdu Wintrue Holding Co., Ltd. announced that they will report first half, 2026 results on Aug 26, 2026 Annuncio • Jun 10
Chengdu Wintrue Holding Co., Ltd. Announces Final Cash Dividend of the Year 2025 of A Shares, Payable on 17 May 2026 Chengdu Wintrue Holding Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 2.0000000 for year 2025 of A shares. Record date is 16 June 2026. Ex-date is 17 June 2026. Payment date is 17 June 2026. Annuncio • Apr 14
Chengdu Wintrue Holding Co., Ltd., Annual General Meeting, May 07, 2026 Chengdu Wintrue Holding Co., Ltd., Annual General Meeting, May 07, 2026, at 14:00 China Standard Time. Location: 9F, Office Building, No. 98, Rongdu Avenue South 2nd Section, Xindu District, Chengdu, Sichuan China Annuncio • Mar 31
Chengdu Wintrue Holding Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Chengdu Wintrue Holding Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Annuncio • Dec 31
Chengdu Wintrue Holding Co., Ltd. to Report Fiscal Year 2025 Results on Apr 15, 2026 Chengdu Wintrue Holding Co., Ltd. announced that they will report fiscal year 2025 results on Apr 15, 2026 Annuncio • Sep 30
Chengdu Wintrue Holding Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Chengdu Wintrue Holding Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Annuncio • Jul 02
Chengdu Wintrue Holding Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025 Chengdu Wintrue Holding Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025 Annuncio • Mar 31
Chengdu Wintrue Holding Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Chengdu Wintrue Holding Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Annuncio • Mar 25
Chengdu Wintrue Holding Co., Ltd. Proposes Final Dividend for 2024 Chengdu Wintrue Holding Co., Ltd. proposed final dividend of CNY 1.00000000 per 10 shares (tax included) for 2024. Annuncio • Mar 24
Chengdu Wintrue Holding Co., Ltd., Annual General Meeting, May 06, 2025 Chengdu Wintrue Holding Co., Ltd., Annual General Meeting, May 06, 2025, at 14:00 China Standard Time. Location: 9F, Office Building, No. 98, Rongdu Avenue South 2nd Section, Xindu District, Chengdu, Sichuan China Annuncio • Jan 18
Chengdu Wintrue Holding Co., Ltd. Approves 2024 Third Quarter Profit Distribution Plan Chengdu Wintrue Holding Co., Ltd. at its Extraordinary General Meeting of 2025 on 16 January 2025, approved: 2024 third quarter profit distribution plan. The detailed profit distribution plan is as follows: Cash dividend/10 shares (tax included): CNY 1.00000000. Annuncio • Dec 31
Chengdu Wintrue Holding Co., Ltd. to Report Fiscal Year 2024 Results on Mar 22, 2025 Chengdu Wintrue Holding Co., Ltd. announced that they will report fiscal year 2024 results on Mar 22, 2025 Annuncio • Dec 26
Chengdu Wintrue Holding Co., Ltd. Proposes Cash Dividend for the Third Quarter of 2024 Chengdu Wintrue Holding Co., Ltd. proposed cash dividend of CNY 1.00000000 per 10 shares (tax included) for the third quarter of 2024. Reported Earnings • Oct 26
Third quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.17 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.17 (up from CN¥0.17 in 3Q 2023). Revenue: CN¥4.69b (down 13% from 3Q 2023). Net income: CN¥215.4m (up 5.9% from 3Q 2023). Profit margin: 4.6% (up from 3.8% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥8.39, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥15.12 per share. Annuncio • Sep 30
Chengdu Wintrue Holding Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024 Chengdu Wintrue Holding Co., Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024 Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.13 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.20 (up from CN¥0.13 in 2Q 2023). Revenue: CN¥6.05b (up 19% from 2Q 2023). Net income: CN¥240.4m (up 53% from 2Q 2023). Profit margin: 4.0% (up from 3.1% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 23% per year, which means it is performing significantly worse than earnings. Annuncio • Jun 29
Chengdu Wintrue Holding Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Chengdu Wintrue Holding Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Board Change • May 30
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Yang Fei Zhong was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Declared Dividend • May 12
Dividend of CN¥0.20 announced Shareholders will receive a dividend of CN¥0.20. Ex-date: 16th May 2024 Payment date: 16th May 2024 Dividend yield will be 2.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (32% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 9.6% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 88% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • May 11
Chengdu Wintrue Holding Co., Ltd. Announces Cash Dividend of A Share for the Year 2023, Payable on May 16, 2024 Chengdu Wintrue Holding Co., Ltd. announced cash dividend/10 shares (tax included) of CNY 2.00000000 of A share for the year 2023. Record date is May 15, 2024. Ex-date is May 16, 2024. Payment date is May 16, 2024. Annuncio • May 09
Chengdu Wintrue Holding Co., Ltd. Approves Cash Dividend for the Year 2023 Chengdu Wintrue Holding Co., Ltd. announced that at its Annual General Meeting held on 06 May 2024, approved cash dividend/10 shares (tax included) of CNY 2.00000000 for the year 2023. Reported Earnings • Apr 30
First quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.29 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.18 (down from CN¥0.29 in 1Q 2023). Revenue: CN¥4.95b (down 13% from 1Q 2023). Net income: CN¥213.3m (down 40% from 1Q 2023). Profit margin: 4.3% (down from 6.2% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year. Reported Earnings • Apr 14
Full year 2023 earnings released: EPS: CN¥0.74 (vs CN¥1.48 in FY 2022) Full year 2023 results: EPS: CN¥0.74 (down from CN¥1.48 in FY 2022). Revenue: CN¥21.8b (up 6.2% from FY 2022). Net income: CN¥891.9m (down 40% from FY 2022). Profit margin: 4.1% (down from 7.3% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Annuncio • Apr 13
Chengdu Wintrue Holding Co., Ltd., Annual General Meeting, May 06, 2024 Chengdu Wintrue Holding Co., Ltd., Annual General Meeting, May 06, 2024, at 14:00 China Standard Time. Annuncio • Mar 30
Chengdu Wintrue Holding Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Chengdu Wintrue Holding Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥6.67, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years. Annuncio • Dec 30
Chengdu Wintrue Holding Co., Ltd. to Report Fiscal Year 2023 Results on Apr 13, 2024 Chengdu Wintrue Holding Co., Ltd. announced that they will report fiscal year 2023 results on Apr 13, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.31 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.31 in 3Q 2022). Revenue: CN¥5.39b (up 41% from 3Q 2022). Net income: CN¥203.4m (down 35% from 3Q 2022). Profit margin: 3.8% (down from 8.2% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Annuncio • Sep 30
Chengdu Wintrue Holding Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023 Chengdu Wintrue Holding Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023 Reported Earnings • Aug 26
Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.52 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.52 in 2Q 2022). Revenue: CN¥5.08b (down 9.7% from 2Q 2022). Net income: CN¥157.4m (down 70% from 2Q 2022). Profit margin: 3.1% (down from 9.3% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Annuncio • May 09
Chengdu Wintrue Holding Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023 Chengdu Wintrue Holding Co., Ltd. announced final cash dividend/10 shares (tax included) (A Shares) of CNY 3.00000000 for the year 2022. Record date: 11 May 2023. Ex-date: 12 May 2023. Payment date: 12 May 2023. Annuncio • May 06
Chengdu Wintrue Holding Co., Ltd. Approves Cash Dividend for the Year 2022 Chengdu Wintrue Holding Co., Ltd. announced that at its Annual General Meeting held on 28 April 2023, approved cash dividend/10 shares (tax included) of CNY 3.00000000 for the year 2022. Reported Earnings • Apr 08
Full year 2022 earnings released: EPS: CN¥1.48 (vs CN¥1.23 in FY 2021) Full year 2022 results: EPS: CN¥1.48 (up from CN¥1.23 in FY 2021). Revenue: CN¥20.5b (up 38% from FY 2021). Net income: CN¥1.49b (up 21% from FY 2021). Profit margin: 7.3% (down from 8.3% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 5 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Hong Bing Yu was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.38 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.31 (down from CN¥0.38 in 3Q 2021). Revenue: CN¥3.83b (down 4.3% from 3Q 2021). Net income: CN¥314.5m (down 17% from 3Q 2021). Profit margin: 8.2% (down from 9.4% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 21
Second quarter 2022 earnings released: EPS: CN¥0.52 (vs CN¥0.22 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.52 (up from CN¥0.22 in 2Q 2021). Revenue: CN¥5.62b (up 79% from 2Q 2021). Net income: CN¥522.9m (up 135% from 2Q 2021). Profit margin: 9.3% (up from 7.1% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 8.2% compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Jul 07
Now 25% undervalued Over the last 90 days, the stock is up 11%. The fair value is estimated to be CN¥22.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 24% over the last 3 years. Earnings per share has grown by 74%. Revenue is forecast to grow by 10% in 2 years. Earnings is forecast to grow by 16% in the next 2 years. Valuation Update With 7 Day Price Move • Jun 10
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥18.32, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 324% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.90 per share. Reported Earnings • Apr 29
First quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.18 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.46 (up from CN¥0.18 in 1Q 2021). Revenue: CN¥5.52b (up 87% from 1Q 2021). Net income: CN¥465.3m (up 158% from 1Q 2021). Profit margin: 8.4% (up from 6.1% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 2.6%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. President & Non-Independent Director Song Rui was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Apr 16
Full year 2021 earnings released: EPS: CN¥1.23 (vs CN¥0.49 in FY 2020) Full year 2021 results: EPS: CN¥1.23 (up from CN¥0.49 in FY 2020). Revenue: CN¥14.9b (up 63% from FY 2020). Net income: CN¥1.23b (up 147% from FY 2020). Profit margin: 8.3% (up from 5.4% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 1.7% compared to a 51% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Nov 06
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥13.35, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 221% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥18.14 per share. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.38 (vs CN¥0.18 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥4.01b (up 72% from 3Q 2020). Net income: CN¥377.1m (up 111% from 3Q 2020). Profit margin: 9.4% (up from 7.7% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment deteriorated over the past week After last week's 26% share price decline to CN¥14.97, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 258% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.42 per share. Valuation Update With 7 Day Price Move • Sep 15
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥20.16, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 379% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.72 per share. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.13 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥3.13b (up 35% from 2Q 2020). Net income: CN¥222.9m (up 67% from 2Q 2020). Profit margin: 7.1% (up from 5.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥11.39, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 175% over the past three years. Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment deteriorated over the past week After last week's 20% share price decline to CN¥9.35, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 113% over the past three years. Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment improved over the past week After last week's 36% share price gain to CN¥11.44, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 188% over the past three years. Valuation Update With 7 Day Price Move • May 13
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥8.90, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 66% over the past three years. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.06 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥2.95b (up 37% from 1Q 2020). Net income: CN¥180.6m (up 211% from 1Q 2020). Profit margin: 6.1% (up from 2.7% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 21
Full year 2020 earnings released: EPS CN¥0.49 (vs CN¥0.21 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥9.15b (up 6.1% from FY 2019). Net income: CN¥498.6m (up 134% from FY 2019). Profit margin: 5.4% (up from 2.5% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Feb 20
New 90-day high: CN¥10.52 The company is up 30% from its price of CN¥8.11 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥11.49 per share. Is New 90 Day High Low • Feb 04
New 90-day high: CN¥9.80 The company is up 28% from its price of CN¥7.66 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥11.55 per share. Analyst Estimate Surprise Post Earnings • Jan 26
Revenue beats expectations Revenue exceeded analyst estimates by 0.06%. Over the next year, revenue is forecast to grow 8.5%, compared to a 50% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥8.10, the stock is trading at a trailing P/E ratio of 20.2x, up from the previous P/E ratio of 16.7x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 42%. Is New 90 Day High Low • Jan 13
New 90-day low: CN¥6.71 The company is down 10.0% from its price of CN¥7.45 on 16 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥10.02 per share. Is New 90 Day High Low • Nov 16
New 90-day high: CN¥8.02 The company is up 8.0% from its price of CN¥7.41 on 18 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥9.28 per share. Reported Earnings • Oct 29
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥400.6m, up 84% from the prior year. Total revenue was CN¥8.73b over the last 12 months, up 1.1% from the prior year. Is New 90 Day High Low • Oct 23
New 90-day low: CN¥6.95 The company is down 5.0% from its price of CN¥7.34 on 24 July 2020. The Chinese market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.98 per share.